CD34 Selected Cells for the Treatment of Poor Graft Function after Allogeneic Stem Cell Transplantation-Reference-Cited by-同舟云学术

CD34 Selected Cells for the Treatment of Poor Graft Function after Allogeneic Stem Cell Transplantation

Published:2014-09 Issue:9 Volume:20 Page:1440-1443
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Stasia Alessandra,Ghiso Anna,Galaverna Federica,Raiola Anna Maria,Gualandi Francesca,Luchetti Silvia^ORCID,Pozzi Sarah^ORCID,Varaldo Riccardo,Lamparelli Teresa,Bregante Stefania,Van Lint Maria Teresa,di Grazia Carmen,Bacigalupo Andrea

Funder

Associazione Italiana Ricerca sul Cancro (AIRC)

Fondazione Ricerca Trapianto Midollo Osseo (FARITMO)

Associazione Italiana contro le Leucemie (AIL)

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference13 articles.

1. Boost of CD34 selected peripheral blood cells without further conditioning in patients with poor graft function following allogeneic stem cell transplantation;Larocca;Haematologica,2006

2. Association of an impaired bone marrow microenvironment with secondary poor graft function after allogenic hematopoietic stem cell transplantation;Kong;Biol Blood Marrow Transplant,2013

3. Graft failure in the modern era of allogeneic hematopoietic SCT;Olsson;Bone Marrow Transplant,2013

4. Factors influencing haematological recovery after allogeneic haemopoietic stem cell transplants: graft-versus-host disease, donor type, cytomegalovirus infections and cell dose;Dominietto;Br J Haematol,2001

5. Major ABO blood group mismatch increases the risk for graft failure after unrelated donor hematopoietic stem cell transplantation;Remberger;Biol Blood Marrow Transplant,2007

Cited by 70 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Active infection at the time of CD34+ selected stem cell boost is associated with treatment failure and poor overall survival;Blood Advances;2024-09-10

2. The impact of donor-specific antibodies’ presence on the outcome post-allogeneic hematopoietic stem cell transplantation: a survey from a single center;Frontiers in Oncology;2024-08-21

3. Treatment of post-allogeneic hematopoietic stem cell transplant cytopenias with sequential doses of multipotent mesenchymal stromal/stem cells;Cytotherapy;2024-08

4. Prospects and Potential for Chimerism Analysis after Allogeneic Hematopoietic Stem Cell Transplantation;Cells;2024-06-06

5. Mesenchymal stromal cells in the treatment of pediatric hematopoietic cell transplantation-related complications (graft vs. host disease, hemorrhagic cystitis, graft failure and poor graft function): a single center experience;Frontiers in Pediatrics;2024-05-09